dupixent fda news - Search News

Hosted on MSN · 30m

FDA Approves Dupixent Injections For People Struggling With COPD Symptoms

The FDA has approved Dupixent (dupilumab) as an add-on therapy for adults with poorly controlled COPD, especially those with elevated eosinophil levels. Clinical trials show that Dupixent reduces COPD exacerbations and improves symptoms when combined with inhaled medications,

copdnewstoday · 4h

FDA approves Dupixent for adults with poorly controlled COPD

The FDA has approved Dupixent as an add-on maintenance treatment for adults with poorly controlled COPD and high counts of immune cells.

Monthly Prescribing Reference · 3h

Dupixent Approved as Add-On Maintenance Therapy in COPD

The approval was supported by data from the 52-week, randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS and NOTUS.

1h

Regeneron’s Growth Prospects Bolstered by Dupixent Approval and Promising Oncology Pipeline

Regeneron (REGN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Evan ...

5h

Eli Lilly: Ebglyss To Challenge Dupixent In Atopic Dermatitis

Eli Lilly's Ebglyss gains FDA approval for atopic dermatitis treatment, poised to rival Dupixent with strong performance in ...

3don MSN

Sanofi-Regeneron's Dupixent wins FDA's nod for 'smoker's lung'

The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a ...

2d

US Food and Drug Administration approves 'Dupixent' for treatment of bronchitis

The US Food and Drug Administration FDA has approved French pharmaceutical company Sanofi Dupixent an anti-bronchitis drug ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results